Financhill
Back

Arcus Biosciences Quote, Financials, Valuation and Earnings

Arcus Biosciences Price Quote

$15.56
+0.01 (+5.63%)
(Updated: April 27, 2024 at 4:54 AM ET)

Arcus Biosciences Key Stats

Sell
31
Arcus Biosciences (RCUS) is a Sell

Day range:
$14.59 - $15.62
52-week range:
$12.95 - $25.47
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.84
P/B ratio:
3.06%

Volume:
504.9K
Avg. volume:
631.6K
1-year change:
-13.56%
Market cap:
$1.4B
Revenue:
$117M
EPS:
$-4.15

How Much Does Arcus Biosciences Make?

Is Arcus Biosciences Growing As A Company?

  • What Is Arcus Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.09%
  • What Is Arcus Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Arcus Biosciences Stock Price Performance

  • Did Arcus Biosciences Stock Go Up Last Month?
    Arcus Biosciences share price went down by -6.61% last month
  • Did RCUS's Share Price Rise Over The Last Year?
    RCUS share price fell by -13.56% over the past 1 year

What Is Arcus Biosciences 52-Week High & Low?

Arcus Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arcus Biosciences?

  • How Much Debt Does Arcus Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Arcus Biosciences Have?
    Cash and short term investments quarterly total is $759M
  • What Is Arcus Biosciences’s Book Value Per Share?
    Book value per share is 6.12

Is Arcus Biosciences Cash Flow Positive?

  • What Is RCUS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$306M
  • What Is Arcus Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $33M
  • What Is Arcus Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $194M

Arcus Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    RCUS return on invested capital is -54.72%
  • What Is Arcus Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -25.14%
  • What Is RCUS Return On Equity?
    ROE is a measure of profitability and is -54.72%

Arcus Biosciences Earnings Date & Stock Price

Arcus Biosciences Competitors

  • Who Are Arcus Biosciences's Competitors?
    Below is a list of companies who compete with Arcus Biosciences or are related in some way:
    • Catalyst Pharmaceuticals Inc (CPRX)
    • Gilead Sciences Inc (GILD)
    • Integra Lifesciences Holdings Corp (IART)
    • Palatin Technologies Inc (PTN)
    • Petros Pharmaceuticals Inc (PTPI)

Arcus Biosciences Dividend Yield

Data Unavailable

Arcus Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -8.38%
Revenue: -8.82% 9.54%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 39.67
Upside from Last Price: 155.09%

Major Shareholders

  • How many RCUS shares are owned by institutional investors?
    104.3M RCUS shares are owned by institutional investors
  • How many RCUS shares are owned by insiders?
    5.1M RCUS shares are owned by insiders